A strong stock as of late has been DocuSign (DOCU). Shares have been marching higher, with the stock up 20.3% over the past month. The stock hit a new 52-week high of $80.61 in the previous session.

The latest trading day saw DocuSign (DOCU) settling at $76.66, representing a +2.69% change from its previous close.

CrowdStrike trades at a 192x forward P/E while Docusign sits at 16.7x, a valuation gap that hinges on growth expectations and ...

What Happened? A number of stocks jumped in the afternoon session after software stocks extended gains as the broader stock market undergoes an overhaul regarding the future of the artificial ...

As a result of the expanded IAM capability driving the improved operating efficiencies, DOCU has reported the growing ...

DocuSign (DOCU) surged 4.59% to $80.175, breaking its 52-week high amid strong institutional/retail demand. Product ...

Hoxhunt, the Human Risk Management platform, today announced Secure Behavior Detection and Response, a product that ...

Duet’s $20 monthly entry point undercuts the $100 minimum individual Pro subscription for Dots, but Muse offers a free entry point.

DocuSign integrates its IAM platform into Salesforce, boosting shares 9% as AI-driven contract management gains traction.

$150,000 of DOCUSIGN INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing. This ...

Steven Powell, a 56-year-old former New Hampshire physician, was sentenced Oct. 13 by U.S. District Judge Paul Barbadoro, who recommended that Powell be incarcerated “at the lowest level of custody ...